47 results
6-K
EX-10.1
CYTO
Altamira Therapeutics Ltd
8 Dec 23
Report of Foreign Private Issuer
9:00am
6-K
EX-10.1
CYTO
Altamira Therapeutics Ltd
11 Jul 23
Altamira Therapeutics Announces Pricing of $5.0 Million Public Offering
8:32am
F-1/A
EX-10.44
CYTO
Altamira Therapeutics Ltd
3 Jul 23
Registration statement (foreign) (amended)
7:09pm
F-1
EX-10.41
CYTO
Altamira Therapeutics Ltd
16 Jun 23
Registration statement (foreign)
5:01pm
F-1/A
EX-10.23
CYTO
Altamira Therapeutics Ltd
27 Mar 23
Registration statement (foreign) (amended)
10:33am
F-1/A
EX-10.22
wk4beikoh6h0
22 Mar 23
Registration statement (foreign) (amended)
6:18pm
6-K
EX-10.1
wkbirgkzvgx32ed8y0a
5 Dec 22
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.2
i34wpugsxme 4wls099
5 Dec 22
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
i5syq 02fcwou8gn0x
4 Mar 22
Altamira Therapeutics and Nuance Pharma Enter into Exclusive Licensing and Distribution Agreement for Bentrioâ„¢ in China and Additional Asian Markets
4:01pm
6-K
EX-10.1
3hj9b09c
3 Jun 21
Current report (foreign)
7:36am
6-K
EX-10.2
g910ek94jh0x
3 Dec 20
Auris Medical Holding LTD. Prices $8,000,000 Common Shares Offering Priced At-the-market
5:26pm
6-K
EX-10.1
dr928axd jxn
3 Dec 20
Auris Medical Holding LTD. Prices $8,000,000 Common Shares Offering Priced At-the-market
5:26pm
6-K
EX-10.2
ugu2d57
23 Apr 20
Report of Foreign Private Issuer
4:38pm
6-K
EX-10.1
nlea09smcsvuzlitidpo
23 Apr 20
Report of Foreign Private Issuer
4:38pm
POS AM
EX-10.23
0xoc3w1
20 Mar 19
Prospectus update (post-effective amendment)
4:43pm
6-K
EX-10.1
s016 iaib
2 May 18
Current report (foreign)
4:49pm
6-K
EX-10.2
fhdp5wpptcypy5h8hj22
2 May 18
Current report (foreign)
4:49pm
6-K
EX-10.1
3k3koeyejby4e fua
30 Jan 18
Current report (foreign)
12:00am
6-K
EX-10.1
1f1j7n
11 Oct 17
Auris Medical Announces Share Purchase Agreements with Lincoln Park Capital Fund, LLC
12:00am
6-K
EX-10.3
5bwy3mkmqy
11 Oct 17
Auris Medical Announces Share Purchase Agreements with Lincoln Park Capital Fund, LLC
12:00am